ReviewMedical molecular morphology2012

Mammary cancer gene therapy targeting lymphangiogenesis: VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant.

Masa-Aki Shibata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.